Entero Healthcare Solutions Board Approves Employee Stock Option Allotment and Reappoints Key Independent Directors

Entero Healthcare Solutions Board Approves Employee Stock Option Allotment and Reappoints Key Independent Directors

Entero Healthcare Solutions Board Approves Employee Stock Option Allotment and Reappoints Key Independent Directors​

Entero Healthcare Solutions Limited, during a recent board meeting, approved the allotment of equity shares to an eligible employee under its stock option plan. Furthermore, the Board ratified the revised tenure for two key Independent Directors as part of succession planning initiatives.

The company's board made several critical approvals related to corporate structure and governance, encompassing both compensation mechanisms for employees and the continuity of independent directorial oversight.

Employee Stock Option Plan Implementation​

The Board approved the allotment of 1,475 Equity Shares of the Company to an eligible employee exercising options vested under the Entero Employee Stock Option Plan 2023. The shares were issued at a par value of Rs. 10/- per share. This transaction updated the company's total issued share capital.

The key details regarding this stock option issuance are as follows:

ParticularsDetails
Plan NameEntero Employee Stock Option Plan 2023
Date of IssueJune 26, 2026
Number of Shares Issued1,475
Par Value per ShareRs. 10/-
Exercise Price per ShareRs. 804
Premium per ShareRs. 794/-
Total Issued Shares After Issue4,35,23,072
Total Issued Share CapitalRs. 43,52,30,720

Independent Director Tenure Ratification​

The Board also approved the revised tenure for reappointing Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors. This approval aims to facilitate effective succession planning and ensure a smooth transition within the board's composition. The term of Mr. Sujesh Vasudevan, another Non-Executive Independent Director, remains unchanged.

The tenure details for the reappointed directors are presented below:

Director NameTerm of Reappointment
Mr. Rajesh Shashikant DalalSecond term of 4 consecutive years commencing from August 25, 2026, to August 24, 2030.
Ms. Sandhya Gadkari SharmaSecond term of 4 consecutive years commencing from August 25, 2026, to August 24, 2030.

Director Profiles and Background​

Mr. Rajesh Shashikant Dalal is a mechanical Engineer from IIT Madras and holds an MBA from Jamanalal Bajaj Institute Bombay. He has over 35 years of experience as a healthcare leader and previously served as Managing Director of Johnson & Johnson India, later taking Asia-wide responsibility for M&A at the company. Post-Johnson & Johnson, he has consulted with private equity firms on healthcare opportunities and helped various international companies formulate their India strategies.

Ms. Sandhya Gadkari Sharma possesses over four decades of experience in Banking and Investment. She obtained her bachelor's degree of Commerce from the University of Bombay and holds a master's in management studies from the University of Bombay. Her prior associations include Mahindra and Mahindra Limited and ICICI Bank Limited.

ENTERO Stock Price Movement​

On Thursday, shares of Entero Healthcare Solutions Limited edged higher, closing at ₹1180.40 after a 1.44% gain. The equity traded within tight limits during the session, ranging from a low of ₹1145.2 to a high of ₹1197.9.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:

Editorial Note

This news article was written and created by Shreyas, and published on IST.
Back
Top